Glutathione and lipid peroxide changes in pseudoexfoliation syndrome

Current Eye Research

Volumn 30, Issue 8, 2005, Pages 647-651

  Gartaganis, Sotirios P ^a   Georgakopoulos, C D ^a   Patsoukis, N E ^b   Gotsis, S S ^c   Gartaganis, V S ^b   Georgiou, C D ^b  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Aqueous humor; Cataract; Glutathione; Lipid peroxidation; Pseudoexfoliation syndrome

Indexed keywords

GLUTATHIONE; GLUTATHIONE DISULFIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; CATARACT; CATARACT EXTRACTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FLUORESCENCE ANALYSIS; HUMAN; LIPID PEROXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOEXFOLIATION;

AGED; AGED, 80 AND OVER; AQUEOUS HUMOR; EXFOLIATION SYNDROME; FEMALE; GLUTATHIONE; GLUTATHIONE DISULFIDE; HUMANS; LIPID PEROXIDATION; LIPID PEROXIDES; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROSPECTIVE STUDIES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 24944555309     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680590968367     Document Type: Article

References (23)

1. Ritch R, Schlötzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol. 2001;45:265-315.
2. Ritch R. Exfoliation syndrome. Curr Opin Ophthalmol. 2001;12:124-130.
3. Streeten BW, Dark AJ, Wallace RN, Li ZY, Hoepner JA. Pseudoexfoliative fibrillopathy in the skin of patients with ocular pseudoexfoliation. Am J Ophthalmol. 1990;110:490-499.
4. Schlötzer-Schrehardt UM, Koca MR, Naumann GO, Volkholz H. Pseudoexfoliation syndrome. Ocular manifestation of a systemic disorder? Arch Ophthalmol. 1992;110:1752-1756.
5. Streeten BW, Li ZY, Wallace RN, Eagle RC Jr, Keshegegian AA. Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome. Arch Ophthalmol. 1992;110:1757-1762.
6. Konstas AG, Marshall GE, Lee WR. Immunogold localization of laminin in normal and exfoliative iris. Br J Ophthalmol. 1990;74:450-457.
7. Koliakos GG, Konstas AG, Triantos A, Ritch R. Increased growth factor activity in the aqueous humor of patients with exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol. 2000;238:491-495.
8. Gartaganis SP, Georgakopoulos CD, Exarchou AM, Mela EK, Lamari F, Karamanos NK. Increased aqueous humor basic fibroblast growth factor and hyaluronan levels in relation to the exfoliation syndrome and exfoliative glaucoma. Acta Ophthalmol Scand. 2001;79:572-575.
9. Gartaganis SP, Georgakopoulos CD, Mela EK, Exarchou A, Ziouti N, Assouti M, Vynios DH. Matrix metalloproteinases and their inhibitors in exfoliation syndrome. Ophthalmic Res. 2000;34:165-171.
10. Schlötzer-Schrehardt U, Zenkel M, Kuchle M, Sakai LY, Naumann GO. Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome. Exp Eye Res. 2001;73:765-780.
11. Micelli-Ferrari T, Vendemiale G, Grattagliano I, Boscia F, Arnese L, Altomare E, Cardia L. Role of lipid peroxidation in the pathogenesis of myopic and senile cataract. Br J Ophthalmol. 1996;80:840-843.
12. Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, Sakaguchi H, Kamei M, Hasan A, Yan L, Rayborn ME, et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA 2002;99:14682-14687.
13. Koliakos GG, Konstas AGP, Schlötzer-Schrehardt U, Bufidis T, Georgiadis N, Ringvold A. Ascorbic acid concentration is reduced in the aqueous humor of patients with exfoliation syndrome. Am J Ophthalmol. 2002;134:879-883.
14. Chylack LT Jr, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL, Friend J, McCarthy D, Wu SY. The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol. 1993;111:831-836.
15. Zamora R, Alaiz M, Hidalgo JF. Feed-back inhibition of oxidative stress by oxidized lipid/amino acid reaction products. Biochemistry. 1997;36:15765-15771.
16. Hissin JP, Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem. 1976;74:214-226.
17. 2. Free Radic Biol Med. 1998;24:632-642.
18. Donma O, Yorulmaz E, Pekel H, Suyugul N. Blood and lens lipid peroxidation and antioxidant status in normal individuals, senile and diabetic cataractous patients. Curr Eye Res. 2002;25:9-16.
19. Babizhayev MA, Deyev AI. Lens opacity induced by lipid peroxidation products as a model of cataract associated with retinal disease. Biochim Biophys Acta. 1989;1004:124-133.
20. Babizhayev MA, Deyev AI, Linberg LF. Lipid peroxidation as a possible cause of cataract. Mech Ageing Dev. 1988;44:69-89.
21. Obara Y. The oxidative stress in the cataract formation. Nippon-Ganka-Gakkai-Zasshi. 1995;99:1303-1341.
22. 2. Invest Ophthalmol Vis Sci. 1998;39:1188-1197.
23. Townsend DM, Tew KD, Tapiero H. The importance of glutathione in human disease. Biomed Pharmacother. 2003;57:321-325.